Novoic
Latest round
- Seed
Last raised
- Mar 2020
Total raised
- $2.5M
Investors
- 5
About Novoic
Based in London, UK, and founded in 2019 by co-founders Emil Fristed (CEO) and Jack Anthony, Novoic Ltd operates as a provider of advanced AI-based diagnostic solutions to health care providers, helping in accurate medical assessments. The company provides a healthcare AI platform that offers speech analysis solutions to medical specialists. The platform's services include diagnostic tools, patient monitoring systems, and medical data analysis. Moreover, the firm offers solutions such as predictive modeling. Additionally, the firm also provides services such as medical data analysis.
Who invested in Novoic
5 investors across 1 round
See all investors in Novoic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 12, 2020
Amount
$2.5M
Investors
Questions about Novoic
Who invested in Novoic?
Novoic has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novoic raised?
Novoic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Novoic last raise money?
Novoic's most recent round on record is a Seed, in Mar 2020.
What does Novoic do?
Based in London, UK, and founded in 2019 by co-founders Emil Fristed (CEO) and Jack Anthony, Novoic Ltd operates as a provider of advanced AI-based diagnostic solutions to health care providers, helping in accurate medical assessments.
Where is Novoic headquartered?
Novoic is headquartered in London, UK.
Which VCs invest in companies like Novoic?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back healthcare it companies at Novoic's stage. Their profiles are linked below.
VCs backing healthcare it startups at Seed
Raising like Novoic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.